SNT 25.7% 4.4¢ syntara limited

short selling action, page-13

  1. 4,694 Posts.
    lightbulb Created with Sketch. 72
    Postmanpat I gave you a TU for your first post in this thread but someone took it off. Made me laugh.

    IMO Shorters don't participate in capital raises's, so therefore don't help to build a company. Now that may well be okay for most companies where they're not trying to develop drugs that are trying to change peoples lives or in fact save them, but in PXS's case a lower share price makes it more difficult to find the investors to do the next capital investment required to develop a drug. Once again IMO plenty of other over priced companies to short, but in PXS's case I don't know how they can sleep at night knowing that they are profiting from destroying lives potentially.

    But we have what we have and capitalism = evolution and survival of the fittest. Let's hope PXS can get these drugs to those that want them and benefit from them.



 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.009(25.7%)
Mkt cap ! $52.53M
Open High Low Value Volume
3.6¢ 4.4¢ 3.6¢ $183.9K 4.656M

Buyers (Bids)

No. Vol. Price($)
1 1159 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 997342 3
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.